Zenas Biopharma (usa), Llc
Clinical trials sponsored by Zenas Biopharma (usa), Llc, explained in plain language.
-
New pill aims to halt MS progression in landmark trial
Disease control Recruiting nowThis study tests whether a daily medication called orelabrutinib can slow or prevent worsening disability in people with primary progressive multiple sclerosis (PPMS), a form of MS that steadily gets worse over time. About 705 adults aged 18 to 60 with PPMS and recent disability …
Phase: PHASE3 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope for slowing progressive MS: phase 3 trial launches
Disease control Recruiting nowThis phase 3 trial tests whether the drug orelabrutinib can slow disability progression in people with non-active secondary progressive multiple sclerosis (SPMS). About 990 adults aged 18-60 will be randomly assigned to receive either orelabrutinib or a placebo for 12 to 60 month…
Phase: PHASE3 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated May 20, 2026 11:58 UTC